Median follow-up period
WebJan 30, 2024 · Study subjects and follow-up period. Patients who initiated indapamide from January 2007 to December 2016 were identified using CDARS. Hospital admissions due to hypokalaemia, as the primary diagnosis of admission, were identified from January 2007 to December 2024 among these patients. ... The median ages on both initial therapy and …
Median follow-up period
Did you know?
WebApr 12, 2024 · The median OS was 50.8 months, mean PFS was 96.5 months (median not reached), mean LC was 101.4 months (median not reached) and median follow-up time was 38.1 months (2.9–148.5 months). Persistence or recurrence was confirmed in 59 (31.2%) patients, a duplicate malignant tumour developed in 23 (12.2%) patients. ... During the … WebApr 14, 2024 · The median duration of antibiotics was 58 days (IQR 56–84) ranging from 42 to 112 days. Among antibiotics, piperacillin–tazobactam was the first line of treatment in 16 cases and all of them needed to be shifted to meropenem due to clinical non-response.
WebApr 14, 2024 · The median duration of antibiotics was 58 days (IQR 56–84) ranging from 42 to 112 days. Among antibiotics, piperacillin–tazobactam was the first line of treatment in … WebMalignant transformation occurred in 15 of 461 patients (3.3%) at a median follow-up period of 192 months. The median follow-up duration was 89.4 months. Multivariate analysis revealed that local recurrence was an independent prognostic factor for unfavorable malignant transformation.
WebMay 9, 2024 · During the follow-up period, the most common were renal disease (23.1%), chronic pulmonary disease (20.5%), diabetes without complications (20.1%), malignancies (16.8%), hypertension (15.0%), myocardial infarction (14.7%), and congestive heart failure (13.2%). Table 2 Comorbidities in the study population with myasthenia gravis (N = 1149) WebOne from date of diagnosis till date of last known follow-up (var X). Another from date of diagnosis till recurrence or death (if one of these or both occur) by calculating both from date of...
WebWe define commonly used measures of follow-up in clinical studies. Results: We explain how each measure should be assessed to evaluate the stability of the Kaplan-Meier …
WebMar 20, 2024 · Kaplan-Meier MAE rate estimates at one and three years of follow-up were 19% and 45% in the acute group, and 43% and 64% in the sequelae group. Patients who … cryo insuranceWebThe median survival is approximately 11 years. A flat survival curve (i.e. one that stays close to 1.0) suggests very good survival, whereas a survival curve that drops sharply toward 0 … cryoin 読み方WebOct 16, 2024 · Thus, a median of 2 months is the shortest follow-up period required to achieve some confidence that any protection against Covid-19 is likely to be more than … cryo intercoolerWebHow do I calculate the median follow up period of a certain study? Is it from the end of treatment to the last follow up? Or, is it from the best response to last follow up? If it's the... cryo in uaWebMar 31, 2024 · Over a median follow-up period of 76 months, it was found that excessive PAC were associated with a >60% increase in the risk of death or stroke, and a 2.7-fold increase in the development of AF. cryo investment summitWebExamples of follow-up period in a sentence, how to use it. 23 examples: What is the optimal follow-up period? - There was no mortality in the follow-up… cryo interactive entertainmentWebDec 1, 2024 · Further, there is an increasing recognition that the median follow-up time does not directly measure the “completeness of the follow-up”: e.g., the median follow-up can be low with excellent follow-up, and it can be high with poor follow-up [18, 20,21,22]. While time to event studies must have sufficient length of follow-up to capture ... cryoix